Discovery Labs inks development deal for therapy targeting premature infants – Philadelphia Business Journal (blog)

Discovery Labs inks development deal for therapy targeting premature infants
Philadelphia Business Journal (blog)
In addition, Battelle received two warrants to purchase a total of 1.5 million shares of Discovery Labs’ common stock at an exercise price of $5 per share. Each warrant carries a 10-year term. Discovery Labs stock is trading at $1.69 per share. Page 1; 2.

…read more

About The Author

error: Content is protected !!
Scroll to Top